This retrospective, single‐center study included all patients aged 18 to 65 years who presented with ACS and underwent ...

Lung development and function is notoriously difficult to study. Both are affected by a range of environmental factors, such as first- and second-hand smoke, air pollution, and infections and genetic ...

The medication, suzetrigine (JOURNAVX (R) ), was FDA-approved in January 2025 and became available at HSS in April 2025. It is the first non-opioid pain reliever released in more than 25 years.

Not Just for Complicated CasesWhile preanesthesia clinics (PACs) are well-established in many Western countries, their ...